Brian Stevens Net Worth

The estimated Net Worth of Brian Stevens is at least $2.36 Million dollars as of 28 February 2022. Mr. Stevens owns over 2,500 units of Baxter International stock worth over $550,212 and over the last 12 years he sold BAX stock worth over $1,814,662. In addition, he makes $0 as Senior Vice President, Chief Accounting Officer, and Controller at Baxter International.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Stevens BAX stock SEC Form 4 insiders trading

Brian has made over 61 trades of the Baxter International stock since 2013, according to the Form 4 filled with the SEC. Most recently he sold 2,500 units of BAX stock worth $213,750 on 28 February 2022.

The largest trade he's ever made was exercising 70,257 units of Baxter International stock on 10 September 2013 worth over $786,878. On average, Brian trades about 10,326 units every 32 days since 2012. As of 28 February 2022 he still owns at least 14,011 units of Baxter International stock.

You can see the complete history of Mr. Stevens stock trades at the bottom of the page.

Brian Stevens biography

Brian Stevens serves as Senior Vice President, Chief Accounting Officer, Controller of the company. Mr. Stevens previously served with Groupon, Inc. (“Groupon”) as Chief Accounting Officer (from September 2012 through May 2016) and as Treasurer and Chief Accounting Officer (from May 2016 through November 2018). Prior to joining Groupon, Mr. Stevens spent 16 years with KPMG LLP, most recently as a partner. Mr. Stevens spent five years in KPMG’s Department of Professional Practice and was a practice fellow at the Financial Accounting Standards Board from 2006 to 2008. Mr. Stevens is a member of the American Institute of Certified Public Accountants and served on its Financial Reporting Executive Committee (FinREC) from November 2013 to January 2018.

How old is Brian Stevens?

Brian Stevens is 44, he's been the Senior Vice President, Chief Accounting Officer, and Controller of Baxter International since 2018. There are 29 older and no younger executives at Baxter International. The oldest executive at Baxter International Inc. is James Gavin, 74, who is the Independent Director.

What's Brian Stevens's mailing address?

Brian's mailing address filed with the SEC is ONE BAXTER PARKWAY, , DEERFIELD, IL, 60015.

Insiders trading at Baxter International

Over the last 22 years, insiders at Baxter International have traded over $966,809,165 worth of Baxter International stock and bought 178,227 units worth $6,261,495 . The most active insiders traders include Point Llc Loeb Daniel S Third, Michael F Mahoney, and Jeffrey A Craig. On average, Baxter International executives and independent directors trade stock every 37 days with the average trade being worth of $3,609,738. The most recent stock trade was executed by Jeanne K Mason on 1 March 2024, trading 64,488 units of BAX stock currently worth $2,397,019.

What does Baxter International do?

baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.

Complete history of Mr. Stevens stock trades at on Inc and Baxter International

Baxter International executives and stock owners

Baxter International executives and other stock owners filed with the SEC include:

• Jose Almeida,
  Chairman of the Board, President, Chief Executive Officer
• James Saccaro,
  Chief Financial Officer, Executive Vice President
• Jeanne Mason,
  Senior Vice President - Human Resources
• Giuseppe Accogli,
  Senior Vice President, President- America
• Sean Martin,
  Senior Vice President, General Counsel
• Cristiano Franzi,
  Senior Vice President and President, EMEA
• Jose E. Almeida,
  Chairman, Pres & CEO
• Cristiano Franzi,
  Sr. VP & Pres for EMEA
• Giuseppe Accogli,
  Exec. VP & COO
• James K. Saccaro,
  Exec. VP & CFO
• Sean B. W. Martin,
  Sr. VP & Gen. Counsel
• Thomas Stallkamp,
  Lead Independent Director
• Albert Stroucken,
  Independent Director
• Peter Hellman,
  Independent Director
• James Gavin,
  Independent Director
• Patricia Morrison,
  Independent Director
• Stephen Oesterle,
  Independent Director
• Amy Wendell,
  Independent Director
• John Forsyth,
  Independent Director
• Michael Mahoney,
  Independent Director
• Cathy Smith,
  Independent Director
• Thomas Chen,
  Independent Director
• Jacqueline Kunzler,
  Senior Vice President and Chief Quality Officer
• Andrew Frye,
  Senior Vice President and President, APAC
• Brian Stevens,
  Senior Vice President, Chief Accounting Officer, Controller
• David S. Rosenbloom,
  Sr. VP & Gen. Counsel
• Clare Trachtman,
  VP of Investor Relations
• Brian C. Stevens,
  Sr. VP, Chief Accounting Officer & Controller
• Wilber C. Boren IV,
  Pres of Advanced Surgery
• Andrew Frye,
  Sr. VP & Pres of APAC
• Jeanne K. Mason,
  Sr. VP of HR
• Stacey Eisen,
  Sr. VP of Global Communications
• Talvis P. Love,
  Sr. VP & Chief Information Officer
• David P. Scharf,
  Corporate Vice President
• Kees J Storm,
  Director
• Marcus Schabacker,
  CVP, Chief Scientific Officer
• Robert Felicelli,
  CVP, Quality
• Brik V Eyre,
  CVP, Hospital Products
• Carole J Uhrich,
  Director
• Paul Vibert,
  CVP, International
• Scott Pleau,
  CVP - Operations
• Caroline Karp,
  CVP, Controller
• Point Llc Loeb Daniel S Third,
  
• Christopher A. Toth,
  EVP,Group Pres, Kidney Care
• William A. Ii Ampofo,
  Director
• Steven Flynn,
  SVP, President, APAC
• Peter M Wilver,
  Director
• David Brent Shafer,
  Director
• Thomas J Jr Sabatino,
  Senior Vice President
• Yuan Chia Pei,
  Director
• Cheryl L White,
  Corporate Vice President
• Joy A Amundson,
  Corporate Vice President
• Jill M Schaaf,
  CVP, Renal
• Harry M Jansen Jr Kraemer,
  Chairman and
• Robert J. Hombach,
  Corporate Vice President & CFO
• James E Utts,
  Corporate Vice President
• Uma Chowdhry,
  Director
• Peter J Arduini,
  Corporate Vice President
• Bruce Mc Gillivray,
  Corporate Vice President
• Sebastian J Bufalino,
  Corporate Vice President
• Jean Luc Butel,
  Corporate Vice President
• James M Gatling,
  Corporate Vice President
• John C Moon,
  Corporate Vice President
• Salto Carlos Del,
  Senior Vice President
• Wayne T Hockmeyer,
  Director
• Joseph B Martin,
  Director
• Michael J Baughman,
  Corporate Vice President
• Steven J Meyer,
  Treasurer
• Michael J Tucker,
  Senior Vice President
• James R Hurley,
  Corporate Vice President
• Monroe E Trout,
  Director
• Thomas Fang Tyan Chen,
  Director
• Nevelle J Jeharajah,
  Corporate Vice President
• Robert M Davis,
  Corp. VP, CFO and Treasurer
• Jan Stern Reed,
  Corporate Secretary
• Thomas H Glanzmann,
  Senior Vice President
• Walter E Boomer,
  Director
• Gail D Fosler,
  Director
• Phillip L. Batchelor,
  Corporate Vice President
• Karenann K Terrell,
  Corporate Vice President
• Robert L Jr Parkinson,
  Chairman of the Board and
• Karen J May,
  Corporate Vice President
• Timothy P Lawrence,
  CVP, Operations
• Blake E Devitt,
  Director
• John J Greisch,
  Senior Vice President & CFO
• Munib Islam,
  Director
• Gregory P Young,
  Corporate Vice President
• Susan R Lichtenstein,
  Corporate Vice President,
• Lawrence T Gibbons,
  Corporate Vice President
• David F Drohan,
  Senior Vice President
• Fred L Turner,
  Director
• Norbert G Riedel,
  Corporate Vice President
• Brian P Anderson,
  Senior Vice President
• Ludwig Hantson,
  Corporate Vice President
• David S. Wilkes,
  Director
• Nancy M Schlichting,
  Director
• Joel T. Grade,
  EVP and CFO
• Alok Sonig,
  EVP,Group President, Pharma
• David S. Rosenbloom,
  EVP and General Counsel
• Heather Knight,
  EVP,Group Pres,Med Products
• Reazur Rasul,
  EVP,Group Pres, Healthcare
• Jeffrey A Craig,
  Director
• Stephen H Rusckowski,
  Director
• James W Borzi,
  EVP,Chief Supply Chain Officer